Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both
PaperCitations, authors & open-access status
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 88 citations, 2016 year and bronze oa status.
88
Citations
2016
Year
bronze
OA Status